ST7-mediated suppression of tumorigenicity of prostate cancer cells is characterized by remodeling of the extracellular matrix

[1]  B. le Bail,et al.  Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma , 1999, The Journal of pathology.

[2]  R. Timpl,et al.  Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: characterization of the binding of vitronectin to osteonectin (BM40, SPARC). , 1997, The Biochemical journal.

[3]  J. Beaulieu,et al.  Expression of SPARC/osteonectin/BM4O in the human gut: Predominance in the stroma of the remodeling distal intestine , 2001, Journal of cellular biochemistry.

[4]  Alan Mackay,et al.  Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. , 2004, Cancer research.

[5]  I. Bièche,et al.  Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer , 1992, The Lancet.

[6]  David I. Smith,et al.  Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors , 1998, Oncogene.

[7]  E. Tobias,et al.  Absence of ST7 mutations in tumor-derived cell lines and tumors , 2001, Nature Genetics.

[8]  Li Jiang,et al.  Somatic mutation analysis of p53 and ST7 tumor suppressor genes in gastric carcinoma by DHPLC. , 2003, World journal of gastroenterology.

[9]  I. Campbell,et al.  Mutation of the ST7 tumor suppressor gene on 7q31.1 is rare in breast, ovarian and colorectal cancers , 2001, Nature Genetics.

[10]  P. Stanhope-Baker,et al.  The Wilms Tumor Suppressor-1 Target Gene Podocalyxin Is Transcriptionally Repressed by p53* , 2004, Journal of Biological Chemistry.

[11]  Sharmistha Pal,et al.  Human SWI/SNF-Associated PRMT5 Methylates Histone H3 Arginine 8 and Negatively Regulates Expression of ST7 and NM23 Tumor Suppressor Genes , 2004, Molecular and Cellular Biology.

[12]  G. Mills,et al.  Functional evidence for an ovarian cancer tumor suppressor gene on chromosome 22 by microcell-mediated chromosome transfer , 2000, Oncogene.

[13]  E. Green,et al.  Definitive functional evidence for a tumor suppressor gene on human chromosome 7q31.1 neighboring the Fra7G site , 2000, Oncogene.

[14]  Joseph Cheung,et al.  The RAY1/ST7 tumor-suppressor locus on chromosome 7q31 represents a complex multi-transcript system. , 2002, Genomics.

[15]  C. Mantzoros,et al.  The Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical Applications , 2002, Oncology.

[16]  M. Oishi,et al.  Chromosome 7 suppresses indefinite division of nontumorigenic immortalized human fibroblast cell lines KMST-6 and SUSM-1. , 1993, Molecular and cellular biology.

[17]  P. Parsons,et al.  Novel markers for poor prognosis in head and neck cancer , 2005, International journal of cancer.

[18]  F. Castellino,et al.  Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse. , 2003, Physiological genomics.

[19]  R. Brekken,et al.  Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM. , 2003, The Journal of clinical investigation.

[20]  Qiwei Yang,et al.  Neuroblastoma Angiogenesis Is Inhibited with a Folded Synthetic Molecule Corresponding to the Epidermal Growth Factor-Like Module of the Follistatin Domain of SPARC , 2004, Cancer Research.

[21]  Angeliki Kotsianti,et al.  WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin , 2001, Current Biology.

[22]  S. Scherer,et al.  Identification of a novel gene on chromosome 7q31 that is interrupted by a translocation breakpoint in an autistic individual. , 2000, American journal of human genetics.

[23]  C. Sassetti,et al.  Identification of Podocalyxin-like Protein as a High Endothelial Venule Ligand for L-selectin: Parallels to CD34 , 1998, The Journal of experimental medicine.

[24]  Carl W. Miller,et al.  Frequent loss of heterozygosity in the region of the D7S523 locus in advanced ovarian cancer , 1997, Genes, chromosomes & cancer.

[25]  R. Berkowitz,et al.  SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells. , 2001, The American journal of pathology.

[26]  E. Green,et al.  Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31 , 2001, Nature Genetics.

[27]  S. Dedhar,et al.  SPARC Regulates Extracellular Matrix Organization through Its Modulation of Integrin-linked Kinase Activity* , 2005, Journal of Biological Chemistry.

[28]  David I. Smith,et al.  Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas , 1997, Oncogene.

[29]  Lois E. H. Smith,et al.  Molecular profiling of angiogenesis markers. , 2002, The American journal of pathology.

[30]  I. Bièche,et al.  (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Lack of mutations within ST7 gene in tumour-derived cell lines and primary epithelial tumours , 2002, British Journal of Cancer.

[32]  M. Reed,et al.  Matricellular homologs in the foreign body response: hevin suppresses inflammation, but hevin and SPARC together diminish angiogenesis. , 2005, The American journal of pathology.